FIRST RESPONDERS' FIRST CHOICE

Serial Number 97573065
606

Registration Progress

Application Filed
Aug 31, 2022
Under Examination
Feb 28, 2023
Approved for Publication
Jan 3, 2023
Published for Opposition
Jan 3, 2023
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: FIRST RESPONDERS' FIRST CHOICE
Previous Owner: Emergent Operations Ireland Limited
Classes: 005, 044

Trademark Image

FIRST RESPONDERS' FIRST CHOICE

Basic Information

Serial Number
97573065
Filing Date
August 31, 2022
Published for Opposition
January 3, 2023
Abandonment Date
September 29, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Sep 29, 2025
Classes
005 044

Rights Holder

Emergent Operations Ireland Limited

99
Address
6th Floor, 6 Earlsfort Terrace
Dublin 2
IE

Ownership History

Emergent Operations Ireland Limited

Original Applicant
99
Dublin IE

Emergent Operations Ireland Limited

Owner at Publication
99
Dublin IE

Legal Representation

Attorney
Virginia Wolk Marino

USPTO Deadlines

All Deadlines Cleared

All 1 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

32 events
Date Code Type Description Documents
Sep 29, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Sep 29, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Feb 21, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 20, 2025 EX4G S SOU EXTENSION 4 GRANTED Loading...
Feb 20, 2025 EXT4 S SOU EXTENSION 4 FILED Loading...
Feb 20, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 18, 2024 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Jun 17, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 17, 2024 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jun 17, 2024 EXT3 S SOU EXTENSION 3 FILED Loading...
Jun 17, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 15, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 22, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 21, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
Feb 21, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Feb 21, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 10, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 8, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Aug 8, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Aug 8, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 28, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 3, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 3, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 14, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 28, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 28, 2022 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Nov 28, 2022 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Nov 28, 2022 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Nov 28, 2022 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Nov 22, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 19, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 3, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, opioid antagonists and narcotic antagonists; pharmaceutical and drug preparations for use in treatment of opiate, opioid or narcotic overdose; Auto-injectors, syringes, intranasal drug delivery devices, spray pump devices for nasal delivery, and devices for nasal delivery, all pre-filled with pharmaceuticals, namely, opioid antagonists and narcotic antagonists and pharmaceutical and drug preparations for use in treatment of opiate, opioid or narcotic overdose; nasal spray preparations
Class 044
Providing a website for patients, medical professionals, and pharmacists featuring information in the fields of opioids and narcotics, opioid antagonists and narcotic antagonists, drug overdoses, and emergency medical tips; providing a website featuring pharmaceutical drug information relating to diagnostic, prophylactic and therapeutic properties of naloxone, opioid antagonists and narcotic antagonists

Classification

International Classes
005 044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"FIRST RESPONDERS'"